Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Hepatitis

  Free Subscription


Articles published in Vaccine

Retrieve available abstracts of 81 articles:
HTML format
Text format



Single Articles


    March 2017
  1. XU B, Zhu D, Bi Y, Wang Y, et al
    Minimal association of alleles of human leukocyte antigen class II gene and long-term antibody response to hepatitis B vaccine vaccinated during infancy.
    Vaccine. 2017 Mar 17. pii: S0264-410X(17)30327.
    PubMed     Text format     Abstract available


    February 2017
  2. CHAPPUIS F, Farinelli T, Deckx H, Sarnecki M, et al
    Immunogenicity and estimation of antibody persistence following vaccination with an inactivated virosomal hepatitis A vaccine in adults: A 20-year follow-up study.
    Vaccine. 2017 Feb 9. pii: S0264-410X(17)30080.
    PubMed     Text format     Abstract available


    January 2017
  3. ABARA WE, Collier MG, Teshale EH
    Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015.
    Vaccine. 2017 Jan 20. pii: S0264-410X(17)30039.
    PubMed     Text format     Abstract available


  4. KARVONEN T, Auranen K, Kuusi M, Leino T, et al
    Epidemiology of hepatitis B infection in Finland: Implications for immunisation policy.
    Vaccine. 2017;35:412-418.
    PubMed     Text format     Abstract available


  5. WANG Y, Chen T, Lu LL, Wang M, et al
    Adolescent booster with hepatitis B virus vaccines decreases HBV infection in high-risk adults.
    Vaccine. 2017 Jan 6. pii: S0264-410X(16)31296.
    PubMed     Text format     Abstract available


    December 2016
  6. ZITT E, Hafner-Giessauf H, Wimmer B, Herr A, et al
    Response to active hepatitis B vaccination and mortality in incident dialysis patients.
    Vaccine. 2016 Dec 31. pii: S0264-410X(16)31257.
    PubMed     Text format     Abstract available


  7. SAKAI A, Noguchi E, Fukushima T, Tagawa M, et al
    Identification of amino acids in antigen-binding site of class II HLA proteins independently associated with hepatitis B vaccine response.
    Vaccine. 2016 Dec 30. pii: S0264-410X(16)30764.
    PubMed     Text format     Abstract available


  8. KANG W, Li Q, Shen L, Zhang L, et al
    Risk factors related to the failure of prevention of hepatitis B virus Mother-to-Child transmission in Yunnan, China.
    Vaccine. 2016 Dec 22. pii: S0264-410X(16)31223.
    PubMed     Text format     Abstract available


    November 2016
  9. ALANKO BLOME M, Bjorkman P, Flamholc L, Jacobsson H, et al
    Vaccination against hepatitis B virus among people who inject drugs - A 20year experience from a Swedish needle exchange program.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31102.
    PubMed     Text format     Abstract available


  10. LU Y, Liang XF, Wang FZ, Yan L, et al
    Hepatitis B vaccine alone may be enough for preventing hepatitis B virus transmission in neonates of HBsAg (+)/HBeAg (-) mothers.
    Vaccine. 2016 Nov 25. pii: S0264-410X(16)31123.
    PubMed     Text format     Abstract available


  11. KULKARNI SP, Thanapati S, Arankalle VA, Tripathy AS, et al
    Specific memory B cell response and participation of CD4+ central and effector memory T cells in mice immunized with liposome encapsulated recombinant NE protein based Hepatitis E vaccine candidate.
    Vaccine. 2016;34:5895-5902.
    PubMed     Text format     Abstract available


  12. THOMPSON C, Dey A, Fearnley E, Polkinghorne B, et al
    Impact of the national targeted Hepatitis A immunisation program in Australia: 2000-2014.
    Vaccine. 2016 Nov 18. pii: S0264-410X(16)31021.
    PubMed     Text format     Abstract available


  13. LIN X, Yang J, Lu H, Zhou Y, et al
    Minimization of hepatitis B infection among children in Jiangsu, China, 12years after integration of hepatitis B vaccine into the expanded program on immunization.
    Vaccine. 2016 Nov 17. pii: S0264-410X(16)31069.
    PubMed     Text format     Abstract available


  14. YU HT, Wang JY, Tian D, Wang MX, et al
    Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.
    Vaccine. 2016 Nov 11. pii: S0264-410X(16)30998.
    PubMed     Text format     Abstract available


    October 2016
  15. ZHANG X, Wei M, Sun G, Wang X, et al
    Real-time stability of a hepatitis E vaccine (Hecolin(R)) demonstrated with potency assays and multifaceted physicochemical methods.
    Vaccine. 2016 Oct 25. pii: S0264-410X(16)30980.
    PubMed     Text format     Abstract available


  16. XEUATVONGSA A, Datta SS, Moturi E, Wannemuehler K, et al
    Improving hepatitis B birth dose in rural Lao People's Democratic Republic through the use of mobile phones to facilitate communication.
    Vaccine. 2016 Oct 11. pii: S0264-410X(16)30883.
    PubMed     Text format     Abstract available


    August 2016
  17. FAN W, Chen XF, Shen C, Guo ZR, et al
    Hepatitis B vaccine response in obesity: A meta-analysis.
    Vaccine. 2016 Aug 18. pii: S0264-410X(16)30699.
    PubMed     Text format     Abstract available


    July 2016
  18. PATEL MK, Wannemuehler K, Tairi R, Tutai R, et al
    Progress towards achieving hepatitis B control in the Cook Islands, Niue, Tokelau, and Kiribati.
    Vaccine. 2016 Jul 8. pii: S0264-410X(16)30563.
    PubMed     Text format     Abstract available


    June 2016
  19. ZHANG L, Yan B, Xu A
    A hepatitis E outbreak by genotype 4 virus in Shandong province, China.
    Vaccine. 2016 Jun 15. pii: S0264-410X(16)30409.
    PubMed     Text format     Abstract available


  20. HANKIN-WEI A, Rein DB, Hernandez-Romieu A, Kennedy MJ, et al
    Cost-effectiveness analysis of catch-up hepatitis a vaccination among unvaccinated/partially-vaccinated children.
    Vaccine. 2016 Jun 14. pii: S0264-410X(16)30464.
    PubMed     Text format     Abstract available


  21. SONDLANE TH, Mawela L, Razwiedani LL, Selabe SG, et al
    High prevalence of active and occult hepatitis B virus infections in healthcare workers from two provinces of South Africa.
    Vaccine. 2016 Jun 2. pii: S0264-410X(16)30366.
    PubMed     Text format     Abstract available


    May 2016
  22. DINDA AK, Bhat M, Srivastava S, Kottarath SK, et al
    Novel nanocarrier for oral Hepatitis B vaccine.
    Vaccine. 2016 May 6. pii: S0264-410X(16)30258.
    PubMed     Text format     Abstract available


    April 2016
  23. ZHU FC, Sun KX, Pan HX, Yang ZH, et al
    The immunogenicity in healthy infants and efficiency to prevent mother to child transmission of Hepatitis B virus of a 10mug recombinant yeast-derived Hepatitis B vaccine (Hep-KSC).
    Vaccine. 2016 Apr 23. pii: S0264-410X(16)30196.
    PubMed     Text format     Abstract available


  24. LEVANDER S, Sallberg M, Ahlen G, Frelin L, et al
    A non-human hepadnaviral adjuvant for hepatitis C virus-based genetic vaccines.
    Vaccine. 2016 Apr 21. pii: S0264-410X(16)30171.
    PubMed     Text format     Abstract available


  25. SADOH AE, Nwaneri DU, Ogboghodo BC, Sadoh WE, et al
    Effect of introduction of pentavalent vaccine as replacement for Diphtheria-Tetanus-Pertussis and Hepatitis B vaccines on vaccination uptake in a health facility in Nigeria.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30164.
    PubMed     Text format     Abstract available


  26. BERAN J, Van Der Meeren O, Leyssen M, D'silva P, et al
    Immunity to hepatitis A and B persists for at least 15 years after immunisation of adolescents with a combined hepatitis A and B vaccine.
    Vaccine. 2016 Apr 20. pii: S0264-410X(16)30174.
    PubMed     Text format     Abstract available


  27. VAN DER MEEREN O, Behre U, Crasta P
    Immunity to hepatitis B persists in adolescents 15-16 years of age vaccinated in infancy with three doses of hepatitis B vaccine.
    Vaccine. 2016 Apr 16. pii: S0264-410X(16)30142.
    PubMed     Text format     Abstract available


  28. ROH EY, Yoon JH, In JW, Lee N, et al
    Association of HLA-DP variants with the responsiveness to Hepatitis B virus vaccination in Korean Infants.
    Vaccine. 2016 Apr 12. pii: S0264-410X(16)30087.
    PubMed     Text format     Abstract available


  29. ALLISON RD, Teleb N, Al Awaidy S, Ashmony H, et al
    Hepatitis B control among children in the Eastern Mediterranean Region of the World Health Organization.
    Vaccine. 2016 Apr 2. pii: S0264-410X(16)30059.
    PubMed     Text format     Abstract available


    March 2016
  30. KOLWAITE AR, Xeuatvongsa A, Ramirez-Gonzalez A, Wannemuehle K, et al
    Hepatitis B vaccine stored outside the cold chain setting: a pilot study in rural Lao PDR.
    Vaccine. 2016 Mar 31. pii: S0264-410X(16)30077.
    PubMed     Text format     Abstract available


  31. WIESEN E, Diorditsa S, Li X
    Progress towards hepatitis B prevention through vaccination in the Western Pacific, 1990-2014.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30056.
    PubMed     Text format     Abstract available


  32. DULAL P, Wright D, Ashfield R, Hill AV, et al
    Potency of a thermostabilised chimpanzee adenovirus Rift Valley fever vaccine in cattle.
    Vaccine. 2016 Mar 25. pii: S0264-410X(16)30057.
    PubMed     Text format     Abstract available


  33. FEIRING B, Laake I, Molden T, Haberg SE, et al
    Do selective immunisation against tuberculosis and hepatitis B reach the targeted populations? A nationwide register-based study evaluating the recommendations in the Norwegian Childhood Immunisation Programme.
    Vaccine. 2016 Mar 3. pii: S0264-410X(16)00255.
    PubMed     Text format     Abstract available


  34. FUSTER F, Vargas JI, Jensen D, Sarmiento V, et al
    CD4/CD8 ratio as a predictor of the response to HBV vaccination in HIV-positive patients: A prospective cohort study.
    Vaccine. 2016 Mar 2. pii: S0264-410X(16)00236.
    PubMed     Text format     Abstract available


    February 2016
  35. SALAMA II, Sami SM, Salama SI, Rabah TM, et al
    Immune response to second vaccination series of hepatitis B virus among booster dose non-responders.
    Vaccine. 2016 Feb 27. pii: S0264-410X(16)00231.
    PubMed     Text format     Abstract available


  36. KUMAR M, Upadhyay A, Singh J, Chhabra M, et al
    Effect of change in sequence of administration of DTwP and Hepatitis B vaccines on perception of pain in infants: A randomized control trial.
    Vaccine. 2016 Feb 19. pii: S0264-410X(16)00173.
    PubMed     Text format     Abstract available


    January 2016
  37. WANG ZZ, Li MQ, Wang P, Yang ZX, et al
    Comparative immunogenicity of hepatitis B vaccine with different dosages and schedules in healthy young adults in China.
    Vaccine. 2016 Jan 19. pii: S0264-410X(16)00044.
    PubMed     Text format     Abstract available


  38. XIA M, Wei C, Wang L, Cao D, et al
    A trivalent vaccine candidate against hepatitis E virus, norovirus, and astrovirus.
    Vaccine. 2016 Jan 9. pii: S0264-410X(16)00017.
    PubMed     Text format     Abstract available


  39. BACKES S, Jager C, Dembek CJ, Kosinska AD, et al
    Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice.
    Vaccine. 2016 Jan 6. pii: S0264-410X(15)01871.
    PubMed     Text format     Abstract available


    December 2015
  40. DOEDEE AM, Kannegieter N, Ozturk K, van Loveren H, et al
    Higher numbers of memory B-cells and Th2-cytokine skewing in high responders to hepatitis B vaccination.
    Vaccine. 2015 Dec 22. pii: S0264-410X(15)01799.
    PubMed     Text format     Abstract available


  41. HUMMEL IB, Zitzmann A, Erl M, Wenzel JJ, et al
    Characteristics of immune memory 10-15 years after primary hepatitis B vaccination.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01824.
    PubMed     Text format     Abstract available


  42. PITTMAN PR, McClain D, Quinn X, Coonan KM, et al
    Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans.
    Vaccine. 2015 Dec 21. pii: S0264-410X(15)01821.
    PubMed     Text format     Abstract available


  43. PITTMAN PR, Norris SL, Brown ES, Ranadive MV, et al
    Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolates.
    Vaccine. 2015 Dec 16. pii: S0264-410X(15)01775.
    PubMed     Text format     Abstract available


  44. KUMAR A, Das S, Mullick R, Lahiri P, et al
    Immune responses against hepatitis C virus genotype 3a virus-like particles in mice: A novel VLP prime-adenovirus boost strategy.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01727.
    PubMed     Text format     Abstract available


  45. JING M, Wang J, Zhu S, Ao F, et al
    Development of a more efficient hepatitis B virus vaccine by targeting hepatitis B virus preS to dendritic cells.
    Vaccine. 2015 Dec 12. pii: S0264-410X(15)01750.
    PubMed     Text format     Abstract available


  46. CHONWATTANA W, Raengsakulrach B, Holtz TH, Wasinrapee P, et al
    Hepatitis B vaccination uptake and correlates of serologic response among HIV-infected and uninfected men who have sex with men (MSM) in Bangkok, Thailand.
    Vaccine. 2015 Dec 9. pii: S0264-410X(15)01765.
    PubMed     Text format     Abstract available


  47. VAN EFFELTERRE T, Marano C, Jacobsen KH
    Modeling the hepatitis A epidemiological transition in Thailand.
    Vaccine. 2015 Dec 1. pii: S0264-410X(15)01702.
    PubMed     Text format     Abstract available


    November 2015
  48. WIESEN E, Lagani W, Sui G, Arava J, et al
    Assessment of the hepatitis B birth dose vaccination program, Papua New Guinea, 2014.
    Vaccine. 2015 Nov 24. pii: S0264-410X(15)01686.
    PubMed     Text format     Abstract available


  49. SU FH, Huang YL, Sung FC, Su CT, et al
    Annual influenza vaccination reduces total hospitalization in patients with chronic hepatitis B virus infection: A population-based analysis.
    Vaccine. 2015 Nov 21. pii: S0264-410X(15)01585.
    PubMed     Text format     Abstract available


    October 2015
  50. KLEVENS RM, Denniston MM, Jiles-Chapman RB, Murphy TV, et al
    Decreasing immunity to hepatitis a virus infection among US adults: Findings from the National Health and Nutrition Examination Survey (NHANES), 1999-2012.
    Vaccine. 2015 Oct 14. pii: S0264-410X(15)01420.
    PubMed     Text format     Abstract available


    September 2015
  51. TESHALE EH, Kamili S, Drobeniuc J, Denniston M, et al
    Hepatitis B virus infection in northern Uganda: Impact of pentavalent hepatitis B vaccination.
    Vaccine. 2015 Sep 29. pii: S0264-410X(15)01334.
    PubMed     Text format     Abstract available


  52. DAVID MC, Ha SH, Paynter S, Lau C, et al
    A systematic review and meta-analysis of management options for adults who respond poorly to hepatitis B vaccination.
    Vaccine. 2015 Sep 27. pii: S0264-410X(15)01327.
    PubMed     Text format     Abstract available


  53. ZHENG H, Wang FZ, Zhang GM, Zhou F, et al
    An economic analysis of adult hepatitis B vaccination in China.
    Vaccine. 2015 Sep 15. pii: S0264-410X(15)01269.
    PubMed     Text format     Abstract available


  54. KIYOHARA T, Ishii K, Mizokami M, Sugiyama M, et al
    Seroepidemiological study of hepatitis B virus markers in Japan.
    Vaccine. 2015 Sep 1. pii: S0264-410X(15)01161.
    PubMed     Text format     Abstract available


    August 2015
  55. MANSFIELD KL, Banyard AC, McElhinney L, Johnson N, et al
    Rift Valley fever virus: A review of diagnosis and vaccination, and implications for emergence in Europe.
    Vaccine. 2015 Aug 18. pii: S0264-410X(15)01134.
    PubMed     Text format     Abstract available


  56. MOON SH, Shin EC, Noh YW, Lim YT, et al
    Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
    Vaccine. 2015 Aug 10. pii: S0264-410X(15)01120.
    PubMed     Text format     Abstract available


  57. YOUNG MK, Faddy HM, Fryk J, Nimmo GR, et al
    Hepatitis A virus antibodies in Australian blood donors: Implications for immunoglobulin sufficiency.
    Vaccine. 2015 Aug 10. pii: S0264-410X(15)01111.
    PubMed     Text format     Abstract available


  58. WEISS T, Zhang D, Borse NN, Walter EB, et al
    Initiation & completion rates of hepatitis A vaccination among US pediatric populations born between 2005 and 2009.
    Vaccine. 2015 Aug 7. pii: S0264-410X(15)01032.
    PubMed     Text format     Abstract available


    July 2015
  59. WHO
    Hepatitis E vaccine: WHO position paper, May 2015 - Recommendations.
    Vaccine. 2015 Jul 29. pii: S0264-410X(15)01017.
    PubMed     Text format     Abstract available


  60. ZHANG Y, Zeng H, Liu P, Liu L, et al
    Hepatitis E vaccine immunization for rabbits to prevent animal HEV infection and zoonotic transmission.
    Vaccine. 2015 Jul 23. pii: S0264-410X(15)00987.
    PubMed     Text format     Abstract available


  61. MULLAERT J, Abgrall S, Lele N, Batteux F, et al
    Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
    Vaccine. 2015 Jul 22. pii: S0264-410X(15)00983.
    PubMed     Text format     Abstract available


  62. THEETEN H, Van Herck K, Van Der Meeren O, Crasta P, et al
    Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions.
    Vaccine. 2015 Jul 16. pii: S0264-410X(15)00936.
    PubMed     Text format     Abstract available


  63. CHOTUN N, Nel E, Cotton MF, Preiser W, et al
    Hepatitis B virus infection in HIV-exposed infants in the Western Cape, South Africa.
    Vaccine. 2015 Jul 8. pii: S0264-410X(15)00877.
    PubMed     Text format     Abstract available


  64. MELGACO JG, Morgado LN, Santiago MA, Oliveira JM, et al
    A single dose of inactivated hepatitis A vaccine promotes HAV-specific memory cellular response similar to that induced by a natural infection.
    Vaccine. 2015 Jul 2. pii: S0264-410X(15)00916.
    PubMed     Text format     Abstract available


  65. KANG G, Ma F, Chen H, Yang Y, et al
    Efficacy of antigen dosage on the hepatitis B vaccine response in infants born to hepatitis B-uninfected and hepatitis B-infected mothers.
    Vaccine. 2015 Jul 2. pii: S0264-410X(15)00896.
    PubMed     Text format     Abstract available


    June 2015
  66. CHEN S, Zhou Z, Wei FX, Huang SJ, et al
    Modeling the long-term antibody response of a hepatitis E vaccine.
    Vaccine. 2015 Jun 27. pii: S0264-410X(15)00839.
    PubMed     Text format     Abstract available


  67. XIAO M, Qiu Q, Pang X, Liang X, et al
    Immune response in infants after universal high-dose hepatitis B vaccination: A community-based study in Beijing, China.
    Vaccine. 2015 Jun 25. pii: S0264-410X(15)00795.
    PubMed     Text format     Abstract available


  68. DENNISTON MM, Monina Klevens R, Jiles RB, Murphy TV, et al
    Self-reported hepatitis A vaccination as a predictor of hepatitis A virus antibody protection in U.S. adults: National Health and Nutrition Examination Survey 2007-2012.
    Vaccine. 2015 Jun 23. pii: S0264-410X(15)00864.
    PubMed     Text format     Abstract available


  69. ZAHID M, Lunsdorf H, Rinas U
    Assessing stability and assembly of the hepatitis B surface antigen into virus-like particles during down-stream processing.
    Vaccine. 2015 Jun 12. pii: S0264-410X(15)00729.
    PubMed     Text format     Abstract available


  70. KHETSURIANI N, Tishkova F, Jabirov S, Wannemuehler K, et al
    Substantial decline in hepatitis B virus infections following vaccine introduction in Tajikistan.
    Vaccine. 2015 Jun 10. pii: S0264-410X(15)00766.
    PubMed     Text format     Abstract available


  71. HAYDEN CA, Fischer ME, Andrews BL, Chilton HC, et al
    Oral delivery of wafers made from HBsAg-expressing maize germ induces long-term immunological systemic and mucosal responses.
    Vaccine. 2015;33:2881-6.
    PubMed     Text format     Abstract available


  72. JANSSEN JM, Jackson S, Heyward WL, Janssen RS, et al
    Immunogenicity of an investigational hepatitis B vaccine with a toll-like receptor 9 agonist adjuvant (HBsAg-1018) compared with a licensed hepatitis B vaccine in subpopulations of healthy adults 18-70 years of age.
    Vaccine. 2015 Jun 8. pii: S0264-410X(15)00743.
    PubMed     Text format     Abstract available


  73. YIN J, Ji Z, Liang P, Wu Q, et al
    The doses of 10mug should replace the doses of 5mug in newborn hepatitis B vaccination in China: A cost-effectiveness analysis.
    Vaccine. 2015 Jun 6. pii: S0264-410X(15)00755.
    PubMed     Text format     Abstract available


  74. LI X, Wiesen E, Diorditsa S, Toda K, et al
    Impact of Adverse Events Following Immunization in Viet Nam in 2013 on chronic hepatitis B infection.
    Vaccine. 2015 Jun 5. pii: S0264-410X(15)00740.
    PubMed     Text format     Abstract available


  75. TANG ZM, Tang M, Zhao M, Wen GP, et al
    A novel linear neutralizing epitope of hepatitis E virus.
    Vaccine. 2015 Jun 4. pii: S0264-410X(15)00728.
    PubMed     Text format     Abstract available


    May 2015
  76. AVDICOVA M, Crasta PD, Hardt K, Kovac M, et al
    Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Vaccine. 2015;33:2727-33.
    PubMed     Text format     Abstract available


  77. ESTRIPEAUT D, Contreras R, Tinajeros O, Castrejon MM, et al
    Impact of Hepatitis A vaccination with a two-dose schedule in Panama: Results of epidemiological surveillance and time trend analysis.
    Vaccine. 2015 May 14. pii: S0264-410X(15)00610.
    PubMed     Text format     Abstract available


  78. TSYBALOVA LM, Stepanova LA, Kuprianov VV, Blokhina EA, et al
    Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
    Vaccine. 2015 May 11. pii: S0264-410X(15)00549.
    PubMed     Text format     Abstract available


  79. ISHII K, Kiyohara T, Yoshizaki S, Kawabata K, et al
    Epidemiological and genetic analysis of a 2014 outbreak of hepatitis A in Japan.
    Vaccine. 2015 May 6. pii: S0264-410X(15)00525.
    PubMed     Text format     Abstract available


    February 2015
  80. KAWANO Y, Suzuki M, Kawada JI, Kimura H, et al
    Effectiveness and safety of immunization with live-attenuated and inactivated vaccines for pediatric liver transplantation recipients.
    Vaccine. 2015 Feb 6. pii: S0264-410X(15)00132.
    PubMed     Text format     Abstract available


  81. WICHGERS SCHREUR PJ, Kant J, van Keulen L, Moormann RJ, et al
    Four-segmented Rift Valley fever virus induces sterile immunity in sheep after a single vaccination.
    Vaccine. 2015 Feb 6. pii: S0264-410X(15)00134.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: